Home
Our laboratory has two areas of interest – eicosanoid biology and molecular clocks.
In the case of eicosanoids, we are interested in the role they play in modulating the immune response in atherosclerosis and cancer, the promotion and restraint of cardiopulmonary fibrosis, in the response to viral infection and in stem cell biology. We are interested in the many factors that contribute to variability in the response to NSAIDs, including the microbiome, genomics, time of drug administration and metabolomics; the use of dynamic and network-based modelling to study drug response and the use of AI and machine learning approaches to develop paradigms predictive of efficacy and risk.
In the case of clocks, we are interested in how a decline in oscillatory function may contribute to age related phenotypes. We are integrating multiple remote sensing approaches with multi-omics analyses to characterize the human chronobiome and to identify time dependent networks that decline with age. Besides affording insight into the trajectory of aging this may afford the opportunity to obtain, in an unbiased fashion, mechanistic insights into time dependent disease phenotypes, such as non-dipping hypertension.
Publications
-
TracMyAir: Smartphone-enabled spatiotemporal estimates for inhaled doses of particulate matter and ozone to personalize health outcomes.
medRxiv : the preprint server for health sciences. 2026 Feb 16; Authors: Lahens NF, Isakov V, Chivily C, Jamal NE, Mrčela A, FitzGerald GA, Skarke C -
Depression of tryptophan may contribute to adverse effects of naproxen.
Nature communications. 2026 Feb 14; Authors: Ghosh S, Lahens NF, Barekat K, Tang SY, Theken KN, Ricciotti E, Sengupta A, Joshi R, Hu W, Bushman FD, Weljie A, Grosser T, FitzGerald GA -
Role of IL-10 signaling in the circadian control of host response to influenza infection.
Mucosal immunology. 2026 Feb;19(1):1666-1678 Epub 2025 Nov 20; Authors: Forrest KM, Towers ME, Paul O, Cho H, Padmini MV, Naik A, Lim HK, Issah Y, Tang SY, Deshmukh HS, Abt MC, Hudock KM, Eisenlohr LC, Grant GR, Brooks TG, Sengupta S -
Degree of Cyclooxygenase-2 Inhibition Modulates Blood Pressure Response.
Hypertension (Dallas, Tex. : 1979). 2026 Feb;83(2):e25516 Epub 2025 Dec 29; Authors: Theken KN, Ghosh S, Skarke C, Fries S, Lahens NF, Sarantopoulou D, Grant GR, FitzGerald GA, Grosser T -
Concomitant COX-1 and COX-2 suppression is not sufficient to induce enteropathy associated with chronic NSAID use.
The Journal of clinical investigation. 2026 Jan 27; Authors: Barekat K, Ghosh S, Herrmann C, Keat K, Assenmacher CA, Tanes C, Wilson N, Lordan R, Mrčela A, Rauova L, Sengupta A, Das US, Joshi R, Friedman E, Ritchie MD, Bittinger K, Weljie A, Cadwell K, Bushman FD, Wu GD, FitzGerald GA, Ricciotti E